BSE filing, BSE: 543578. Summary written from the filing by ALFA Finder's alert engine.
Olatech Solutions Ltd: key numbers
- Share price
- ₹58.68
- Market cap
- ₹26.12 Cr
- Revenue (annual)
- ₹27.63 Cr
- Net profit (annual)
- ₹1.63 Cr
- P/E (TTM)
- 16.1×Sector 23.0×
- Promoter holding
- 61.49%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Olatech Solutions Ltd
All →Olatech Solutions Annual General Meeting
Olatech Solutions Ltd held its 12th Annual General Meeting on September 30, 2026, to discuss financial adoption, director appointments, and related party transactions.
Olatech Solutions Promoter Selling: ₹0.03 Cr
Navneet Kakkar, part of the promoter group of Olatech Solutions Ltd, sold equity shares worth Rs. 0.03 Crore. The transaction was conducted via open market sales on the BSE.
- Value
- ₹0.03 Cr
Olatech Solutions Management Change
Olatech Solutions Ltd has appointed Mr. Sameer Saluja as its Chief Executive Officer, effective September 25, 2026. He previously served as the company's Chief Sales Officer.
Olatech Solutions Annual General Meeting
Olatech Solutions issued its AGM notice for 30 September 2026. The agenda covers financials adoption, director appointments, and related-party transaction approvals.
Olatech Solutions Annual Report
Olatech Solutions filed its Annual Report for FY 2025-26 with BSE. The submission includes the notice for its 12th AGM.
Olatech Solutions Board Meeting Outcome
Olatech Solutions appointed an additional executive director and statutory auditor. The board also scheduled the company's 12th Annual General Meeting for September 30, 2026.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.